Log in

The burden of skin diseases in China: global burden of Disease Study 2019

  • Original Paper
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Skin diseases continue to affect human health and cause a significant disease burden on the healthcare system.We aimed to report the changing trends in the burden of skin disease in China from 1990 to 2019, Which has an important role in develo** targeted prevention strategies. We applied Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2019 analytical tools to calculate the age-standardized Prevalence and Incidence in 2019, number of years lived with disability (YLDs) and age-standardized YLDs from 1990 to 2019 of skin and subcutaneous diseases, notifiable infectious skin diseases and skin tumors in China. Among the skin and subcutaneous diseases in China in 2019, dermatitis contributed to the greatest YLD (2.17 million, 95% uncertainty interval[UI]: 1.28–3.36). Age-standardized YLD rates for leprosy decreased from 0.09 (95%UI: 0.06–0.13) in 1990 to 0.04 (95%UI: 0.03–0.06) in 2019; the proportional decrease was 55.56% over 30 years. Age-standardized YLDs for HIV and sexually transmitted infections increased by 26% during the same time period. Age-standardized YLDs for non-melanoma skin cancer increased at a much higher rate than melanoma between 1990 and 2019. Dermatitis and scabies continue to have an important role in the burden of skin and subcutaneous disease burden in China. The burden of non-melanoma cell cancer has increased most significantly over the past three decades.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The data sets used and/or analysed during the current study are available from the corresponding author upon reasonable request.

References

  1. World Health Organization Epidemiology and management of common skin diseases in children in develo** countries (Internet). https://iris.who.int/handle/10665/69229

  2. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, Marks R, Naldi L, Weinstock MA, Wulf SK, Michaud C, Murray JL, Naghavi C M (2014) The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. J Invest Dermatol 134(6):1527–1534

    Article  CAS  PubMed  Google Scholar 

  3. Wu JH, Cohen BA (2019) The stigma of skin disease. Curr Opin Pediatr 31(4):509–514

    Article  PubMed  Google Scholar 

  4. Laughter MR, Maymone MBC, Karimkhani C, Rundle C, Hu S, Wolfe S, Abuabara K, Hollingsworth P, Weintraub GS, Dunnick CA, Kisa A, Damiani G, Sheikh A, Singh JA, Fukumoto T, Desai R, Grada A, Filip I, Radfar A, Naghavi M, Dellavalle RP (2020) The Burden of skin and Subcutaneous diseases in the United States from 1990 to 2017. JAMA Dermatol 156(8):874–881

    Article  PubMed  Google Scholar 

  5. Kavita A, Thakur JS, Narang T (2023) The burden of skin diseases in India: global burden of Disease Study 2017. Indian J Dermatol Venereol Leprol 89(3):421–425

    Article  CAS  PubMed  Google Scholar 

  6. Dong W, An J, Geng P, Zeng X, Chen Y, Zhao Z, Zhou M (2020) Years lost due to disability from skin diseases in China 1990–2017: findings from the global burden of Disease Study 2017. Br J Dermatol 182(1):248–250

    CAS  PubMed  Google Scholar 

  7. Peng D, Sun J, Wang J, Qi X, Li G (2021) Burden of skin disease - China, 1990–2019. China CDC Wkly 3(22):472–475

    Article  PubMed  PubMed Central  Google Scholar 

  8. GBD 2019 Diseases and Injuries Collaborators (2020) Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet 396(10258):1204–1222

    Article  Google Scholar 

  9. Salomon JA, Haagsma JA, Davis A, de Noordhout CM, Polinder S (2015) Disability weights for the global burden of Disease 2013 study. Lancet Glob Health 3(11):e712–e723

    Article  PubMed  Google Scholar 

  10. Laughter MR, Maymone MBC, Mashayekhi S, Arents BWM, Karimkhani C, Langan SM (2021) The global burden of atopic dermatitis: lessons from the global burden of Disease Study 1990–2017. Br J Dermatol 184(2):304–309

    Article  CAS  PubMed  Google Scholar 

  11. Langan SM, Irvine AD, Weidinger S (2020) Atopic dermatitis. Lancet 396(10247):345–360

    Article  CAS  PubMed  Google Scholar 

  12. Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI (2009) Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. J Allergy Clin Immunol 124(6):1251–8e23

    Article  PubMed  Google Scholar 

  13. Abuabara K, Yu AM, Okhovat JP, Allen IE, Langan SM (2018) The prevalence of atopic dermatitis beyond childhood: a systematic review and meta-analysis of longitudinal studies. Allergy 73(3):696–704

    Article  CAS  PubMed  Google Scholar 

  14. Sunderkötter C, Wohlrab J, Hamm H (2021) Scabies: epidemiology, diagnosis, and treatment. Dtsch Arztebl Int 118(41):695–704

    PubMed  PubMed Central  Google Scholar 

  15. Seidelman J, Garza RM, Smith CM, Fowler VG Jr (2017) More than a Mite Contagious: Crusted Scabies. Am J Med 130(9):1042–1044

    Article  PubMed  Google Scholar 

  16. Cassell JA, Middleton J, Nalabanda A, Lanza S, Head MG, Bostock J, Hewitt K, Jones CI, Darley C, Karir S, Walker SL (2018) Scabies outbreaks in ten care homes for elderly people: a prospective study of clinical features, epidemiology, and treatment outcomes. Lancet Infect Dis 18(8):894–902

    Article  PubMed  PubMed Central  Google Scholar 

  17. Zhang W, Zhang Y, Luo L, Huang W, Shen X, Dong X, Zeng W, Lu H (2020) Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global Burden of disease study 2017. Emerg Microbes Infect 9(1):813–816

    Article  PubMed  PubMed Central  Google Scholar 

  18. World Health Organization Global leprosy (Hansen disease) update, 2019: time to step-up prevention initiatives (Internet). https://www.who.int/publications/i/item/who-wer9536

  19. Vieira MCA, Nery JS, Paixão ES, Freitas de Andrade KV, Oliveira Penna G, Teixeira MG (2018) Leprosy in children under 15 years of age in Brazil: a systematic review of the literature. PLoS Negl Trop Dis 12(10):e0006788

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dharmawan Y, Fuady A, Korfage I, Richardus JH (2021) Individual and community factors determining delayed leprosy case detection: a systematic review. PLoS Negl Trop Dis 15(8):e0009651

    Article  PubMed  PubMed Central  Google Scholar 

  21. Peiwen S, Wang Le, Wang Hongsheng, Liangbin Yan, Meiwen Yu (2023) Epidemiological characteristics of leprosy in China from 2016 to 2020. Chin J Dermatol 56(3):204–209

    Google Scholar 

  22. Chu T, Liu D, Huai P, Chen X, Han S, Chen S, Zhang F (2020) Comprehensive measures succeeded in improving early detection of leprosy cases in post-elimination era: experience from Shandong province, China. PLoS Negl Trop Dis 14(2):e0007891

    Article  PubMed  PubMed Central  Google Scholar 

  23. Zheng Y, Yu Q, Lin Y, Zhou Y, Lan L, Yang S, Wu J (2022) Global burden and trends of sexually transmitted infections from 1990 to 2019: an observational trend study. Lancet Infect Dis 22(4):541–551

    Article  CAS  PubMed  Google Scholar 

  24. Taylor MM, Frasure-Williams J, Burnett P, Park IU (2016) Interventions to improve sexually transmitted Disease Screening in Clinic-based settings. Sex Transm Dis 43(2 Suppl 1):S28–S41

    Article  PubMed  PubMed Central  Google Scholar 

  25. Rietmeijer CA Improving care for sexually transmitted infections (2019). J Int AIDS Soc 22 Suppl 6 (Suppl Suppl 6):e25349

  26. World Health Organization Report on global sexually transmitted infection surveillance 2018 (Internet). https://www.who.int/reproductivehealth/publications/stissurveillance-2018/en/

  27. World Health Organization Global health sector strategy on sexually transmitted infections 2016–2021 (Internet). https://www.who.int/reproductivehealth/publications/rtis/ghss-stis/en/

  28. Leigh IM (2014) Progress in skin cancer: the U.K. experience. Br J Dermatol 171(3):443–445

    Article  CAS  PubMed  Google Scholar 

  29. Hu W, Fang L, Ni R, Zhang H, Pan G (2022) Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer 22(1):836

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gordon R (2013) Skin cancer: an overview of epidemiology and risk factors. Semin Oncol Nurs 29(3):160–169

    Article  PubMed  Google Scholar 

  31. Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, Artaman A (2017) The Burden of Primary Liver Cancer and underlying etiologies from 1990 to 2015 at the Global, Regional, and National Level: results from the global burden of Disease Study 2015. JAMA Oncol 3(12):1683–1691

    Article  PubMed Central  Google Scholar 

  32. Garcovich S, Colloca G, Sollena P, Andrea B, Balducci L, Cho WC, Bernabei R, Peris K (2017) Skin Cancer epidemics in the Elderly as an emerging issue in geriatric oncology. Aging Dis 8(5):643–661

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

Conceptualization: YK and PH; Data curation: YK and PX; Formal analysis: YK and PX; Methodology: YK; Project administration: PH and FZ; Supervision: PH and FZ; Validation: PX, PH and FZ; Visualization: PH and FZ; Writing-original draft: YK; Writing-review &editing: YK, PX, PH and FZ.

Corresponding author

Correspondence to Pengcheng Huai.

Ethics declarations

Competing interests

The authors declare no competing interests.

Conflict of interest

The authors declare that ther have no conflict of interest to disclose.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kong, Y., **ng, P., Huai, P. et al. The burden of skin diseases in China: global burden of Disease Study 2019. Arch Dermatol Res 316, 277 (2024). https://doi.org/10.1007/s00403-024-03046-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00403-024-03046-5

Keywords

Navigation